Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06332950
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-27
First Post:
2024-03-20
Brief Title:
Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome II With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy
Sponsor:
Baohui Han
Organization:
Shanghai Chest Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-20
First Submit QC Date:
March 20 2024
Study First Post Date:
2024-03-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-20
Last Update Post Date:
2024-03-27
Last Update Post Date Type:
ACTUAL